Commonwealth Equity Services, LLC Heron Therapeutics, Inc. Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 63,676 shares of HRTX stock, worth $101,881. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,676

Previous 56,751 12.2%

Holding current value

$101,881

Previous $199,000 36.18%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$1.73 - $3.67 $11,980 - $25,414	6,925 Added 12.2%	63,676 $127,000
Q2 2024 Jul 31, 2024	SELL	$2.32 - $3.86 $653,718 - $1.09 Million	-281,775 Reduced 83.24%	56,751 $199,000
Q1 2024 Apr 29, 2024	BUY	$1.71 - $3.06 $17,308 - $30,973	10,122 Added 3.08%	338,526 $938,000
Q4 2023 Feb 06, 2024	BUY	$0.54 - $1.82 $7,332 - $24,711	13,578 Added 4.31%	328,404 $558,000
Q3 2023 Oct 23, 2023	BUY	$0.97 - $1.8 $15,972 - $29,640	16,467 Added 5.52%	314,826 $324,000
Q2 2023 Aug 10, 2023	BUY	$1.11 - $2.88 $309,131 - $802,071	278,497 Added 1402.16%	298,359 $346,000
Q1 2023 May 11, 2023	SELL	$1.51 - $3.25 $1,132 - $2,437	-750 Reduced 3.64%	19,862 $29,000
Q4 2022 Feb 07, 2023	SELL	$2.25 - $4.67 $1,181 - $2,451	-525 Reduced 2.48%	20,612 $51,000
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $12,275 - $24,782	4,615 Added 27.93%	21,137 $89,000
Q2 2022 Jul 19, 2022	BUY	$2.3 - $6.29 $11,500 - $31,450	5,000 Added 43.4%	16,522 $46,000
Q1 2022 May 04, 2022	SELL	$4.63 - $9.94 $370 - $795	-80 Reduced 0.69%	11,522 $65,000
Q4 2021 Jan 31, 2022	SELL	$8.35 - $12.6 $162,474 - $245,170	-19,458 Reduced 62.65%	11,602 $105,000
Q3 2021 Oct 29, 2021	SELL	$10.13 - $15.0 $3,758 - $5,565	-371 Reduced 1.18%	31,060 $332,000
Q2 2021 Aug 11, 2021	BUY	$13.27 - $18.48 $6,847 - $9,535	516 Added 1.67%	31,431 $487,000
Q1 2021 May 04, 2021	BUY	$14.49 - $20.72 $53,699 - $76,788	3,706 Added 13.62%	30,915 $501,000
Q4 2020 Feb 11, 2021	SELL	$14.61 - $22.14 $11,965 - $18,132	-819 Reduced 2.92%	27,209 $575,000
Q3 2020 Nov 05, 2020	SELL	$13.67 - $17.77 $28,255 - $36,730	-2,067 Reduced 6.87%	28,028 $415,000
Q2 2020 Aug 12, 2020	BUY	$10.89 - $21.47 $147,080 - $289,973	13,506 Added 81.42%	30,095 $442,000
Q1 2020 May 11, 2020	BUY	$10.23 - $24.56 $44,387 - $106,565	4,339 Added 35.42%	16,589 $194,000
Q4 2019 Feb 05, 2020	BUY	$17.42 - $26.61 $3,484 - $5,322	200 Added 1.66%	12,250 $287,000
Q3 2019 Oct 30, 2019	BUY	$16.36 - $21.39 $197,138 - $257,749	12,050 New	12,050 $222,000

Others Institutions Holding HRTX

# of Institutions

179

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $190M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Heron Therapeutics, Inc. Transaction History